Azole resistance in Aspergillus: A growing public health menace

Future Microbiology

Volumn 6, Issue 11, 2011, Pages 1229-1232

  Denning, David W ^a,b   Perlin, David S ^c  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

Antifungal resistance; Aspergillus; Chronic pulmonary aspergillosis; Itraconazole; Triazoles

Indexed keywords

FUNGICIDE; ITRACONAZOLE; POSACONAZOLE; PYRROLE DERIVATIVE; VORICONAZOLE;

ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; ANTIFUNGAL RESISTANCE; ASPERGILLOSIS; ASPERGILLUS; ASPERGILLUS FUMIGATUS; CROSS RESISTANCE; GENE MUTATION; HUMAN; LUNG ASPERGILLOSIS; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; REVIEW;

ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS; AZOLES; DRUG RESISTANCE, FUNGAL; HUMANS; PUBLIC HEALTH; TREATMENT FAILURE;

ASPERGILLUS;

EID: 81255154131     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.11.118     Document Type: Review

References (21)

1. Walsh TJ, Anaissie EJ, Denning DW et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin. Infect. Dis. 46, 327-360 (2008). (Pubitemid 351265310)
2. Denning DW, Verweij PE. The challenge of invasive aspergillosis: increasing numbers in diverse patient groups. Int. J. Infect. Dis. 2, 61-63 (1997).
3. van der Linden JW, Snelders E, Kampinga GA et al. Prospective surveillance of azole-resistance in Aspergillus fumigatus in the Netherlands. Presented at: The 21st European Congress of Clinical Microbiology and Infectious Diseases 27th International Congress of Chemotherapy (ECCMID 21st, ICC 27th). Milan, Italy, 7-10 May 2011.
4. Denning D, Pleuvry A, Cole D. Global burden of ABPA in adults with asthma and its complication chronic pulmonary aspergillosis. Bull. World Health Organ. (2011) (In Press).
5. Denning DW, Pleuvry A, Cole DC. Global burden of ABPA in adults with asthma and its complication chronic pulmonary aspergillosis. Presented at: The British Thoracic Society Winter Meeting. London, UK 2010
6. Smith NL, Denning DW. Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma. Eur. Respir. J. 37, 865-872 (2011).
7. Denning DW, Venkateswarlu K, Oakley KL et al. Itraconazole resistance in Aspergillus fumigatus. Antimicrob. Agents Chemother. 41, 1364-1368 (1997). (Pubitemid 27231443)
8. Krishnan-Natesan S, Swaminathan S, Cutright J et al. Antifungal susceptibility pattern of Aspergillus fumigatus isolated from clinical specimens in Detroit Medical Center (DMC): rising frequency of High MIC of azoles (2003-2006). Presented at: The 50th Interscience Conference of Antimicrobial Agents and Chemotherapy. Boston, MA, USA, 12-15 September 2010.
9. Martinez M, Cloud G, Chen V, Stevens D. Itraconazole and amphotericin B resistance 1987-2009 in clinical Aspergillus fumigatus in northern California. Presented at: The 4th Advances Against Aspergillosis. Rome, Italy, 4-6 February 2010.
10. Howard SJ, Cerar D, Anderson MJ et al. Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with treatment failure. Emerg. Infect. Dis. 15, 1068-1076 (2009).
11. Bueid A, Howard SJ, Moore CB et al. Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009. J. Antimicrob. Chemother. 65, 2116-2118 (2010).
12. Verweij PE, Howard SJ, Melchers WJ, Denning DW. Azole-resistance in Aspergillus: proposed nomenclature and breakpoints. Drug Resist. Updat. 12, 141-147 (2009).
13. Mortensen KL, Jensen RH, Johansen HK et al. Aspergillus species and other molds in respiratory samples from patients with cystic fibrosis: a laboratory-based study with focus on Aspergillus fumigatus azole resistance. J. Clin. Microbiol. 49, 2243-2251 (2011).
14. Lockhart SR, Zimbeck AJ, Baddley JW et al. In vitro echinocandin susceptibility of Aspergillus isolates from patients enrolled in the Transplant-Associated Infection Surveillance Network. Antimicrob. Agents Chemother. 55(8), 3944-3946 (2011).
15. Denning DW, Park S, Lass-Florl C et al. High-frequency triazole resistance found in nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease. Clin. Infect. Dis. 52, 1123-1129 (2011).
16. Howard SJ, Arendrup MC. Acquired antifungal drug resistance in Aspergillus fumigatus: epidemiology and detection. Med. Mycol. 49(Suppl. 1), S90-S95 (2011).
17. Snelders E, Melchers WJ, Verweij PE. Azole resistance in Aspergillus fumigatus: a new challenge in the management of invasive aspergillosis?. Fut. Microbiol. 6(3), 335-347 (2011).
18. Mellado E, Alcazar-Fuoli L, Garc-a-Effrn G, Alastruey-Izquierdo A, Cuenca-Estrella M, Rodr-guez-Tudela JL. New resistance mechanisms to azole drugs in Aspergillus fumigatus and emergence of antifungal drugs resistant A. fumigatus atypical strains. Med. Mycol. 44, S367-S371 (2006).
19. Verweij PE, Snelders E, Kema GH, Mellado E, Melchers WJ. Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use?. Lancet Infect. Dis. 9, 789-795 (2009).
20. Snelders E, Camps SM, Karawajczyk A et al. Azole-resistance in Aspergillus fumigatus: collateral damage of fungicide use?. Presented at: The 21st European Congress of Clinical Microbiology and Infectious Diseases 27th International Congress of Chemotherapy. Milan, Italy, 7-10 May 2011.
21. Hof H. Critical annotations to the use of azole antifungals for plant protection. Antimicrob. Agents Chemother. 45, 2987-2990 (2001). (Pubitemid 32988818)